结论疏血通注射液具有明显抗凝、促纤溶作用，对急性脑梗死的治疗和预防安全有效。
Conclusion Shuxuetong injection is effective and safe in treatment and prevention of acute cerebral infarction by accelerating fibrinolysis activity and inhibiting coagulation activity.
结论：疏血通注射液对急性缺血性脑卒中的微栓子具有预防和治疗作用；tcd栓子自动监测有助于及时发现微栓子、评估药物疗效。
CONCLUSION: Shuxuetong injection has preventive and therapeutic effects on MES of AIS, TCD automatic embolus monitor helps to find MES in time and evaluate the effect of drugs.
结论：黄芪注射液联合疏血通治疗老年急性脑梗死效果明显，是一种安全有效的干预措施。
CONCLUSION: Huangqi Injection combined with Shuxuetong are effective and safe in treating aged acute cerebral infarction.
前言：为探讨疏血通注射液治疗急性脑梗死瘀血阻络型的疗效，50例病人采用疏血通注射液治疗，观察临床疗效和血液流变学指标的变化。
To observe the clinical effects of "Shuxuetong Injection" in treating acute cerebral infarction of blood-stasis obstruction, 50 subjects were treated with this Injection.
结论：疏血通注射液能促进脑出血时的血肿吸收、血肿周围低密度区缩小和神经功能改善。
Conclusion Shuxuetong injection can promote the absorption of hematoma, reduce the low-density areas surrounding hematomas and improve the neurological function during intracerebral hemorrhage.
目的：观察疏血通注射液和醒脑静注射液治疗急性脑梗死的疗效。
The purpose of observation Shuxuetong injection and XNJI the treatment of acute cerebral infarction.
方法利用高效液相色谱采用梯度洗脱测定疏血通注射液中的氨基酸。
METHODS Amino acid and peptides in Shuxuetong injection were determined with gradient elution.
结论本方法精密度高、稳定性好，可作为疏血通注射液质量分析的有效方法。
CONCLUSION the method is accurate, the stability is good, and it can be used to analyze the quality of Shuxuetong injection.
结论疏血通注射液具有安全、方便、疗效肯定的优点，是治疗急性缺血性脑血管疾病的有效药物。
Conclusion Shuxuetong injection is advantageous in its safety, convenience and efficacy and is the effective drug for acute ischemic cerebral vascular disease.
结论疏血通注射液联合阿托伐他汀钙片治疗CAS临床疗效好，具有改善脂质代谢的作用，值得临床推广应用。
CONCLUSION The Shuxuetong injection combined with atorvastatin in patients with CAS has better clinical efficacy, can improve lipid metabolism and is worthy of clinical application.
结论疏血通注射液联合阿托伐他汀钙片治疗CAS临床疗效好，具有改善脂质代谢的作用，值得临床推广应用。
CONCLUSION The Shuxuetong injection combined with atorvastatin in patients with CAS has better clinical efficacy, can improve lipid metabolism and is worthy of clinical application.
应用推荐